The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Alpine Immune Sciences Common Stock 02083G100   20,864,082 2,029,580 SH   SOLE   2,029,580 0 0
Ikena Oncology Common Stock 45175G108   14,754,247 2,249,123 SH   SOLE   2,249,123 0 0
Immunic Inc Common Stock 4525EP101   4,488,282 1,788,160 SH   SOLE   1,788,160 0 0
Kronos Bio Common Stock 50107A104   6,567,447 3,818,283 SH   SOLE   3,818,283 0 0
Morphic Holding Common Stock 61775R105   17,763,471 309,846 SH   SOLE   309,846 0 0
Nuvation Bio Common Stock Class A 67080N101   27,130,212 15,072,340 SH   SOLE   15,072,340 0 0
Replimune Group Common Stock 76029N106   69,690,627 3,001,319 SH   SOLE   3,001,319 0 0
Sana Biotechnology, Inc. Common Stock 799566104   5,028,750 843,750 SH   SOLE   843,750 0 0
Senti Biosciences, Inc. Common Stock 81726A100   122,762 195,792 SH   SOLE   195,792 0 0
Spruce Biosciences Common Stock 85209E109   4,646,197 2,161,022 SH   SOLE   2,161,022 0 0
Syros Pharmaceuticals Common Stock 87184Q206   791,500 251,270 SH   SOLE   251,270 0 0
Theseus Pharmaceuticals Common Stock 88369M101   6,638,099 711,479 SH   SOLE   711,479 0 0